SEC Form 10-Q filed by Pressure BioSciences, Inc.

9/6/24 5:17:19 PM ET

$PBIO

Get the next $PBIO alert in real time by email

Weekly insight reads limit reached.

Join Quantisnow to enjoy unlimited reads, alerts, live feeds, and more.

Meet Quantisnow

Stock alerts. Live news feeds. Press releases. Insider trading. FDA approvals & more.

Get started Learn more

Invest smarter

A better trading workflow

Access market-moving news before they break out to the general public. Let Quantisnow cut out the noise and only receive insights that matter.

Live feeds: Real-time news feeds for Press Releases, SEC Filings, FDA approvals, market insights and more.
Custom filters: Filter out the noise with company filters, market cap filters, price filters and more.
Audio Squawk: Multitask with confidence and let Quantsinow read breaking news out loud.

Save time

Unlock Insights with AI

Get quick summaries and precise Q&A for every insight, empowering you to make informed decisions without sifting through entire press releases and lengthy SEC filings.

Get alerted immediately

All your stock market alerts in one place

Quantisnow alerts are fast, customizable, and versatile.

Email alerts: Subscribe to your favorite stocks and receive email alerts each time a news pops up.
App notifications: Reduce alerting latency with in-app notifications. Same as email alerts, but faster.
Webhooks: Integrate with Quantisnow programmatically and receive live insights via webhooks
Granular alerts: Want to receive Press Releases but no SEC filings? No problem - Quantisnow alerts are highly customizable and can seemlessly tailor to your trading needs.

Elevate your trading.
Start using Quantisnow today.

Never miss an update.

Get started Learn more

Simple no-tricks pricing

One membership with full access and no delays.

Quantisnow Plus

Your personal trading assistant for just $39/month.

What's included

Live feeds
Audio squawk
Compact mode in feeds
Email alerts
App push alerts
Unlimited insights reads
Unlimited subscriptions
Advanced filters in live feeds
Support
No ads
AI-generated summaries and Q&A

One membership - all access

$39/month

Get access

$39/month with yearly billing, $49/month with monthly billing

News insights ingested and delivered in real time

5 million+

Real-time news alerts sent out to Quantisnow users

700,000+

Latency of news delivery pipelines to users via mobile app, webhooks, and email

<100ms

Get the next $PBIO alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PBIO

Date	Price Target	Rating	Analyst

More analyst ratings

$PBIO
Press Releases

Fastest customizable press release news feed in the world

Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
CANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Thursday, June 20, 2024 at 4:30pm ET. Topics to be discussed include: FY 2023 financial and business results.FY 2024 financial and business outlook.Status of Company's relocation to its new manufacturing facility.Status of Company's new Joint Venture Program.Update on Uncle Bud's Health and WellnessProduct expansion – expected Q3/Q4 2024 release of new nanoemulsified products, i
6/18/24 8:16:05 AM ET
$PBIO
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
SOUTH EASTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Wednesday, June 19, 2024 at 4:30 PM ET. The topics to be discussed include but are not limited to: FY 2023 financial and business results.FY 2024 financial and business outlook.Status of Company's relocation to its new manufacturing facility.Update on Uncle Bud's Health and WellnessProduct expansion – expected Q3/Q4 2024 commercial release of new nanoemulsified products: N
6/13/24 10:13:34 AM ET
$PBIO
Uncle Bud's Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness
SOUTH EASTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services for the health & wellness, food & beverage, nutraceutical, cosmeceutical, and other industries, today revealed that its wholly-owned Uncle Bud's Health & Wellness direct-to-consumer ("DTC") subsidiary ("Uncle Bud's") has announced an expansion of products and categories in 2024 to its recently formed "Premium Collection" of state-of-the-art nanoemulsified products. Premium Collection products
4/11/24 10:52:23 AM ET
$PBIO

$PBIO
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Peterson Jeffrey N acquired $1,670 worth of shares (59,652 units at $0.03), increasing direct ownership by 72% to 142,084 units (SEC Form 4)
4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
9/30/24 4:05:23 PM ET
$PBIO
Director Urdea Michael S acquired $404 worth of shares (14,429 units at $0.03), increasing direct ownership by 44% to 47,588 units (SEC Form 4)
4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
9/30/24 4:05:20 PM ET
$PBIO
President, CEO Schumacher Richard T acquired $641 worth of shares (22,878 units at $0.03), increasing direct ownership by 38% to 82,967 units (SEC Form 4)
4 - PRESSURE BIOSCIENCES INC (0000830656) (Issuer)
9/30/24 4:05:21 PM ET
$PBIO

$PBIO
SEC Filings

SEC Form 10-Q filed by Pressure BioSciences, Inc.
10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
2/7/25 5:30:43 PM ET
$PBIO
SEC Form 10-Q filed by Pressure BioSciences, Inc.
10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
9/6/24 5:17:19 PM ET
$PBIO
SEC Form NT 10-Q filed by Pressure BioSciences, Inc.
NT 10-Q - PRESSURE BIOSCIENCES INC (0000830656) (Filer)
8/19/24 5:20:09 PM ET
$PBIO

$PBIO
Leadership Updates

Live Leadership Updates

Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is excited to announce promising early financial results from its January 19, 2024 acquisition of Uncle Bud's Health & Wellness ("UB"). Key highlights from Uncle Bud's first month following its acquisition by PBIO include: Amazon Business Rapid Growth: Amazon sales have surged, inc
2/26/24 9:06:01 AM ET
$PBIO

$PBIO
Financials

Live finance-specific insights

Uncle Bud's to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness
Multi-Patented Nanoemulsification Platform Enables Wide-Range of Best-in-Class Health and Wellness Products - Revenue Impact of $5 Million in 2024 Anticipated with Further Acceleration in 2025 & Beyond Pressure BioSciences February 5th Investor Call to Discuss Impact of Recent Uncle Bud's Acquisition SOUTH EASTON, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biothe
2/5/24 8:23:04 AM ET
$PBIO
Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023
Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ETSOUTH EASTON, MA / ACCESSWIRE / November 21, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmeceuticals, agriculture, and food & beverage industries, today reported financial results for the third quarter ended September 30, 2023, provided a business update, and offered limited guidance for expected achievements through the remainder of 2023.Financial Highlights: Q3 2023 vs. Q3 2022 (rounded to nearest
11/21/23 9:28:00 AM ET
$PBIO
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Conference Call Scheduled for Tuesday, November 21 at 4:30pm ETSOUTH EASTON, MA / ACCESSWIRE / November 20, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2023 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company's website) approximately one day after the teleconference.The teleconference will include a Company presentation followed by a Question & Answer period.Date: Tuesday, November 21, 2023. Time: 4:30 PM Eastern Time (ET).To attend thi
11/20/23 9:15:00 AM ET
$PBIO

$PBIO
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Pressure BioSciences, Inc. (Amendment)
SC 13G/A - PRESSURE BIOSCIENCES INC (0000830656) (Subject)
7/30/21 2:54:00 PM ET
$PBIO
SEC Form SC 13G filed by Pressure BioSciences, Inc.
SC 13G - PRESSURE BIOSCIENCES INC (0000830656) (Subject)
7/16/21 2:44:13 PM ET
$PBIO

SEC Form 10-Q filed by Pressure BioSciences, Inc.

Weekly insight reads limit reached.

Meet Quantisnow

Invest smarter

Save time

Get alerted immediately

Elevate your trading.Start using Quantisnow today.

Simple no-tricks pricing

Quantisnow Plus

What's included

Chat with this insight

Recent Analyst Ratings for $PBIO

$PBIO Press Releases

Fastest customizable press release news feed in the world

Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET

Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET

Uncle Bud's Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness

$PBIO Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Peterson Jeffrey N acquired $1,670 worth of shares (59,652 units at $0.03), increasing direct ownership by 72% to 142,084 units (SEC Form 4)

Director Urdea Michael S acquired $404 worth of shares (14,429 units at $0.03), increasing direct ownership by 44% to 47,588 units (SEC Form 4)

President, CEO Schumacher Richard T acquired $641 worth of shares (22,878 units at $0.03), increasing direct ownership by 38% to 82,967 units (SEC Form 4)

$PBIO SEC Filings